Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Summary

To assess the efficacy and safety of administration of rhTPO at different time in the treatment of thrombocytopenia caused by first-line GC/GP regimen for non small cell lung cancer (NSCLC)

Timeline

Start

2011-02

Primary completion

2016-08

Completion

2016-08

Drugs

Indications